Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort-Reference-Cited by-全球学者库

Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort

Published:2020-04 Issue:2 Volume:9 Page:269-279
ISSN:2218-6751
Container-title:Translational Lung Cancer Research
language:
Short-container-title:Transl Lung Cancer Res

Author:

Song Yong, ,Hu Chengping,Xie Zhanhong,Wu Lin,Zhu Zhengfei,Rao Chuangzhou,Liu Li,Chen Yuan,Liang Naixin,Chen Jun,Hu Chunhong,Yang Nong,Hu Jie,Zhao Weixin,Tong Gangling,Dong Xiaorong,Zheng Di,Jin Meiling,Chen Jianhua,Huang Meijuan,He Yong,Rosell Rafael,Lippi Giuseppe,Mino-Kenudson Mari,Han-Zhang Han,Mao Xinru,Zhang Lu,Liu Hao,Field John K.,Chuai Shannon,Ye Junyi,Han Yusheng,Lu Shun

Publisher

AME Publishing Company

Subject

Oncology

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical approach and utilizing liquid biopsies to interrogate suspected acquired resistance to PD-1 blockade;Future Science OA;2024-01-31

2. Apatinib added when NSCLC patients get slow progression with EGFR‐TKI: A prospective, single‐arm study;Cancer Medicine;2023-11-30

3. Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article;Cancer Biology & Therapy;2023-11-13

4. Allelic Context of EGFR C797X–Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical Outcomes;Journal of Thoracic Oncology;2023-11

5. Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications;The Journal of Liquid Biopsy;2023-09